Publicaciones en las que colabora con José Luis Martín Ventura (10)

2023

  1. Role of LCN2 in a murine model of hindlimb ischemia and in peripheral artery disease patients, and its potential regulation by miR-138-5P

    Atherosclerosis, Vol. 385

2022

  1. Lipocalin-2 and Calprotectin Potential Prognosis Biomarkers in Peripheral Arterial Disease

    European Journal of Vascular and Endovascular Surgery, Vol. 63, Núm. 4, pp. 648-656

  2. Role of Extracellular Vesicles as Potential Diagnostic and/or Therapeutic Biomarkers in Chronic Cardiovascular Diseases

    Frontiers in Cell and Developmental Biology, Vol. 10

2015

  1. TWEAK/Fn14 interaction promotes oxidative stress through NADPH oxidase activation in macrophages

    Cardiovascular Research, Vol. 108, Núm. 1, pp. 139-147

  2. Thioredoxin-1/peroxiredoxin-1 as sensors of oxidative stress mediated by NADPH oxidase activity in atherosclerosis

    Free Radical Biology and Medicine, Vol. 86, pp. 352-361

2014

  1. Galectin-3, a biomarker linking oxidative stress and inflammation with the clinical outcomes of patients with atherothrombosis

    Journal of the American Heart Association, Vol. 3, Núm. 4

2011

  1. CCL20 is increased in hypercholesterolemic subjects and is upregulated by LDL in vascular smooth muscle cells: Role of NF-κB

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 31, Núm. 11, pp. 2733-2741

2009

  1. Increased CD74 expression in human atherosclerotic plaques: Contribution to inflammatory responses in vascular cells

    Cardiovascular Research, Vol. 83, Núm. 3, pp. 586-594

  2. The CD163-expressing macrophages recognize and internalize TWEAK. Potential consequences in atherosclerosis

    Atherosclerosis, Vol. 207, Núm. 1, pp. 103-110

2007

  1. Identification of soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) as a possible biomarker of subclinical atherosclerosis

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 27, Núm. 4, pp. 916-922